SCHEMBL4929907

SCHEMBL4929907

O=C(O)c1ccc(-n2c(SCc3ccc(Cl)cc3)nc3ccc(Cl)cc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.62
TBXA2R P21731 5/20 0.62
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
PTGDR2 Q9Y5Y4 1/20 0.51
TP53 P04637 3/20 0.51
MAPT P10636 1/20 0.51
THRB P10828 1/20 0.51
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PTGS2 P35354 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925606 0.89 DRD2 (0.52) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4930777 0.88 THRB (0.51) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4924774 0.87 THRB (0.50) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4930115 0.87 DRD2 (0.64) DRD2TBXA2RMEN1KMT2APTGDR2
SCHEMBL4933411 0.87 MAPT (0.55) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4933054 0.87 LMNA (0.49) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4931374 0.86 LMNA (0.48) DRD2TBXA2RPTGDR2TP53MAPT
SCHEMBL4929736 0.86 PTGDR2 (0.48) DRD2TBXA2RMEN1KMT2APTGDR2
SCHEMBL4931232 0.86 DRD2 (0.52) DRD2TBXA2RTP53MAPTTHRB
SCHEMBL4932116 0.85 MAPT (0.54) DRD2TBXA2RMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 DRD2 2198/4885TBXA2R 354/4885MEN1 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.